Trademark: 85033595
Status Date
Friday, March 23, 2018
Registration Number
4013428
Registration Date
Tuesday, August 16, 2011
Filing Date
Saturday, May 8, 2010
Published for Opposition
Tuesday, October 19, 2010
Cancellation Date
Friday, March 23, 2018
5 Extended release tablets, extended release chewable tablets and suspension for oral administration of the drug clonidine, intended for the treatment of hypertension, Tourette's syndrome, attention deficit hyperactivity disorder and autism
Oct 31, 2018
Assignment Of Ownership Not Updated Automatically
Oct 3, 2018
Assignment Of Ownership Not Updated Automatically
Mar 23, 2018
Cancelled Sec. 8 (6-Yr)
Sep 20, 2017
Assignment Of Ownership Not Updated Automatically
Jun 27, 2012
Automatic Update Of Assignment Of Ownership
Aug 16, 2011
Registered-Principal Register
Jul 9, 2011
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 8, 2011
Law Office Registration Review Completed
Jul 8, 2011
Allowed Principal Register - Sou Accepted
Jun 21, 2011
Statement Of Use Processing Complete
Jun 14, 2011
Use Amendment Filed
Jun 21, 2011
Case Assigned To Intent To Use Paralegal
Jun 14, 2011
Teas Statement Of Use Received
Dec 14, 2010
Noa E-Mailed - Sou Required From Applicant
Oct 19, 2010
Official Gazette Publication Confirmation E-Mailed
Oct 19, 2010
Published For Opposition
Sep 13, 2010
Law Office Publication Review Completed
Sep 13, 2010
Assigned To Lie
Aug 31, 2010
Approved For Pub - Principal Register
Aug 19, 2010
Assigned To Examiner
May 15, 2010
Notice Of Pseudo Mark Mailed
May 13, 2010
New Application Office Supplied Data Entered In Tram
May 12, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
